Observational studyViruses2022

Rildo: Real-World Multicenter Study on the Effectiveness and Safety of Single-Tablet Regimen of Dolutegravir plus Rilpivirine in Treatment-Experienced People Living with HIV.

Carmen Hidalgo-Tenorio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.